Status:

COMPLETED

The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening

Lead Sponsor:

Freenome Holdings Inc.

Conditions:

Cancer

Eligibility:

All Genders

30+ years

Brief Summary

This protocol is a case-control, multicenter, diagnostic study to collect blood samples to support the development of blood-based screening tests for multiple cancers.

Eligibility Criteria

Inclusion

  • Key
  • Age at least 30 years
  • Able and willing to provide blood samples per protocol
  • Able to comprehend and willing to sign and date the informed consent documents
  • Participants must meet one of the following:
  • Diagnosed with a single primary cancer that has not yet been treated
  • No evidence or treatment of any cancer for at least 5 years prior to enrollment
  • Key

Exclusion

  • A medical condition which, in the opinion of the investigator, should preclude enrollment in the study
  • Known to be pregnant
  • Any therapy for cancer, including surgery, chemotherapy, immunotherapy, and/or radiation therapy in the 5 years preceding enrollment
  • Participated or currently participating in a clinical research study in which an experimental medication has been administered in the last 30 days
  • Participated in or currently participating in another Freenome clinical study
  • For the control cohort: Any previous cancer diagnosis in the 5 years preceding enrollment, or recurrence of the same primary cancer within any timeframe; or concurrent diagnosis of multiple primary cancers within any timeframe
  • For the cancer cohorts: Any previous cancer diagnosis in the 5 years preceding enrollment, apart from the current cancer diagnosis; OR recurrence of the same primary cancer within any timeframe; OR concurrent diagnosis of multiple primary cancers within any timeframe

Key Trial Info

Start Date :

February 15 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 12 2025

Estimated Enrollment :

7435 Patients enrolled

Trial Details

Trial ID

NCT05254834

Start Date

February 15 2022

End Date

July 12 2025

Last Update

August 22 2025

Active Locations (68)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 17 (68 locations)

1

Central Alabama Research

Birmingham, Alabama, United States, 35209

2

Alabama Oncology

Birmingham, Alabama, United States, 35243

3

Honor Health

Scottsdale, Arizona, United States, 85258

4

Highlands Oncology Group

Springdale, Arkansas, United States, 72762

The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening | DecenTrialz